Division of Hematology
About the Division
In the past year, the Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases continued its growth in the areas of clinical practice, teaching and research. Members of the Division are conducting research in several areas of benign and malignant hematology. In particular, Division faculty members have special strengths in basic, translational and clinical research in the area of viral associated malignancies, including those seen in patients with HIV/AIDS. Members of the Division are also involved in a number of innovative investigator-initiated and National Cooperative Group (e.g., SWOG, AMC) sponsored clinical studies. These trials reflect the broad research interests of our faculty and cover diverse areas, such as conventional chemotherapeutics, small molecules and monoclonal antibodies.
Renowned chemical engineer and nanomedicine pioneer joining USCMark E. Davis, PhD, a renowned chemical engineering professor and nanomedicine pioneer at the California Institute of Technology whose work on biomaterials for cancer treatment holds great promise to make medicines more targeted and effective, will join the USC faculty in October. Davis, one of the few academics selected to the National Academy of Engineering
LAC+USC Medical Center Inpatient Tower Conference Room A, 1983 Marengo St.
11:00 am - 12:30 pm